Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 275

1.

Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.

Leoni MC, Amelung L, Lieveld FI, van den Brink J, de Bruijne J, Arends JE, van Erpecum CP, van Erpecum KJ.

Clin Res Hepatol Gastroenterol. 2018 Sep 12. pii: S2210-7401(18)30170-0. doi: 10.1016/j.clinre.2018.08.006. [Epub ahead of print]

PMID:
30219692
2.

Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults.

McGee EE, Castro FA, Engels EA, Freedman ND, Pfeiffer RM, Nogueira L, Stolzenberg-Solomon R, McGlynn KA, Hemminki K, Koshiol J.

Int J Cancer. 2018 Aug 28. doi: 10.1002/ijc.31835. [Epub ahead of print]

PMID:
30155920
3.

Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.

Peiseler M, Reiners D, Pinnschmidt HO, Sebode M, Jung F, Hartl J, Zenouzi R, Ehlken H, Groth S, Schachschal G, Rösch T, Weiler-Normann C, Lohse AW, Schramm C.

PLoS One. 2018 Aug 20;13(8):e0202686. doi: 10.1371/journal.pone.0202686. eCollection 2018.

4.

Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment.

Pataia V, Papacleovoulou G, Nikolova V, Samuelsson AM, Chambers S, Jansen E, Taylor PD, Poston L, Williamson C.

Int J Obes (Lond). 2018 May 24. doi: 10.1038/s41366-018-0095-0. [Epub ahead of print]

PMID:
29795465
5.

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry.

Kuo A, Gomel R, Safer R, Lindor KD, Everson GT, Bowlus CL.

Clin Gastroenterol Hepatol. 2018 Apr 26. pii: S1542-3565(18)30409-9. doi: 10.1016/j.cgh.2018.04.047. [Epub ahead of print]

PMID:
29705262
6.

The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.

Khan N, Trivedi C, Shah Y, Cole E, Lewis J, Yang YX.

Inflamm Bowel Dis. 2018 Apr 25. doi: 10.1093/ibd/izy106. [Epub ahead of print]

PMID:
29697792
7.

Genistein reduces the activation of AKT and EGFR, and the production of IL6 in cholangiocarcinoma cells involving estrogen and estrogen receptors.

Tanjak P, Thiantanawat A, Watcharasit P, Satayavivad J.

Int J Oncol. 2018 Jul;53(1):177-188. doi: 10.3892/ijo.2018.4375. Epub 2018 Apr 24.

PMID:
29693152
8.

Crohn's Disease Behavior and Location is Altered when Associated with Primary Sclerosing Cholangitis.

Iny O, Yanai H, Matalon S, Santo E, Shibolet O, Dotan I, Maharshak N.

Isr Med Assoc J. 2018 Jan;20(1):25-29.

9.

Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.

Rupp C, Rössler A, Zhou T, Rauber C, Friedrich K, Wannhoff A, Weiss KH, Sauer P, Schirmacher P, Süsal C, Stremmel W, Gotthardt DN.

United European Gastroenterol J. 2018 Mar;6(2):255-262. doi: 10.1177/2050640617717156. Epub 2017 Jun 17.

10.

Aromatase in normal and diseased liver.

Murakami K, Hata S, Miki Y, Sasano H.

Horm Mol Biol Clin Investig. 2018 Feb 28. pii: /j/hmbci.ahead-of-print/hmbci-2017-0081/hmbci-2017-0081.xml. doi: 10.1515/hmbci-2017-0081. [Epub ahead of print]

PMID:
29489455
11.

Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center.

Singh H, Balouch F, Noble C, Lewindon P.

J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):80-85. doi: 10.1097/MPG.0000000000001927.

PMID:
29470284
12.

Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients.

Kubota K, Kamisawa T, Hirano K, Hirooka Y, Uchida K, Ikeura T, Shiomi H, Ohara H, Shimizu K, Arakura N, Kanno A, Sakagami J, Itoi T, Ito T, Ueki T, Nishino T, Inui K, Mizuno N, Yoshida H, Sugiyama M, Iwasaki E, Irisawa A, Okazaki K, Kawa S, Shimosegawa T, Takeyama Y, Chiba T.

J Hepatobiliary Pancreat Sci. 2018 Apr;25(4):223-230. doi: 10.1002/jhbp.541. Epub 2018 Mar 23.

PMID:
29430861
13.

Gender, Race and Disease Etiology Predict De Novo Malignancy Risk following Liver Transplantation: Insights for Future Individualized Cancer Screening Guidance.

Bhat M, Mara K, Dierkhising R, Watt KD.

Transplantation. 2018 Jan 26. doi: 10.1097/TP.0000000000002113. [Epub ahead of print]

PMID:
29377876
14.

Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.

Herzog D, Fournier N, Buehr P, Rueger V, Koller R, Heyland K, Nydegger A, Spalinger J, Schibli S, Petit LM, Braegger CP; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):598-607. doi: 10.1097/MEG.0000000000001072.

PMID:
29360691
15.

Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis.

Carpino G, Cardinale V, Folseraas T, Overi D, Floreani A, Franchitto A, Onori P, Cazzagon N, Berloco PB, Karlsen TH, Alvaro D, Gaudio E.

Am J Pathol. 2018 Mar;188(3):627-639. doi: 10.1016/j.ajpath.2017.11.010. Epub 2017 Dec 15.

PMID:
29248458
16.

Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.

Nordenvall C, Olén O, Nilsson PJ, von Seth E, Ekbom A, Bottai M, Myrelid P, Bergquist A.

Aliment Pharmacol Ther. 2018 Jan;47(2):238-245. doi: 10.1111/apt.14393. Epub 2017 Oct 24.

PMID:
29064110
17.

Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.

Webb GJ, Rana A, Hodson J, Akhtar MZ, Ferguson JW, Neuberger JM, Vierling JM, Hirschfield GM.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):278-287.e7. doi: 10.1016/j.cgh.2017.09.062. Epub 2017 Oct 6.

PMID:
28993258
18.

Primary Sclerosing Cholangitis: What the Gastroenterologist and Hepatologist Needs to Know.

Gossard AA, Gores GJ.

Clin Liver Dis. 2017 Nov;21(4):725-737. doi: 10.1016/j.cld.2017.06.004. Epub 2017 Jul 25. Review.

PMID:
28987259
19.

Long-term Risk of Cancer Following Ileal Pouch-anal Anastomosis for Ulcerative Colitis.

Mark-Christensen A, Erichsen R, Brandsborg S, Rosenberg J, Qvist N, Thorlacius-Ussing O, Hillingsø J, Pachler JH, Christiansen EG, Laurberg S.

J Crohns Colitis. 2018 Jan 5;12(1):57-62. doi: 10.1093/ecco-jcc/jjx112.

PMID:
28981638
20.

Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.

Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK.

World J Gastroenterol. 2017 Sep 7;23(33):6137-6146. doi: 10.3748/wjg.v23.i33.6137.

Supplemental Content

Loading ...
Support Center